1
|
Sadraei SI, Yousif G, Taimoory SM, Kosar M, Mehri S, Alolabi R, Igbokwe E, Toma J, Rahim MMA, Trant JF. The total synthesis of glycolipids from S. pneumoniae and a re‐evaluation of their immunological activity. Chembiochem 2022; 23:e202200361. [DOI: 10.1002/cbic.202200361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2022] [Revised: 07/05/2022] [Indexed: 11/11/2022]
Affiliation(s)
| | - Greg Yousif
- University of Windsor Chemistry and Biochemistry CANADA
| | - S. Maryamdokht Taimoory
- University of Windsor Chemistry and Biochemistry 401 Sunset Ave.Department of Chemistry and Biochemistry N9B3P4 Windsor CANADA
| | - Maryam Kosar
- University of Windsor Chemistry and Biochemistry CANADA
| | - Samaneh Mehri
- University of Windsor Chemistry and Biochemistry CANADA
| | | | | | - Jason Toma
- University of Windsor Biomedical Sciences CANADA
| | | | - John F. Trant
- University of Windsor Chemistry and Biochemistry 401 Sunset Ave. N9B 3P4 Windsor CANADA
| |
Collapse
|
2
|
Compton BJ, Tang CW, Johnston KA, Osmond TL, Hayman CM, Larsen DS, Hermans IF, Painter GF. Synthesis and Activity of 6″-Deoxy-6″-thio-α-GalCer and Peptide Conjugates. Org Lett 2015; 17:5954-7. [PMID: 26606283 DOI: 10.1021/acs.orglett.5b02836] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
A major challenge in the development of highly defined synthetic vaccines is the codelivery of vaccine components (i.e., antigen and adjuvant) to secondary lymphoid tissue to induce optimal immune responses. This problem can be addressed by synthesizing vaccines that comprise peptide antigens covalently attached to glycolipid adjuvants through biologically cleavable linkers. Toward this, a strategy utilizing previously unreported 6″-deoxy-6″-thio analogues of α-GalCer that can undergo chemoselective conjugation with peptide antigens is described. Administration of these conjugate vaccines leads to enhanced priming of antigen specific T cells. This simple vaccine design is broadly applicable to multiple disease indications such as cancer and infectious disease.
Collapse
Affiliation(s)
- Benjamin J Compton
- The Ferrier Research Institute, Victoria University of Wellington , P.O. Box 600, Wellington 6140, New Zealand
| | - Ching-wen Tang
- Malaghan Institute of Medical Research , P.O. Box 7060, Wellington 6242, New Zealand
| | - Karen A Johnston
- The Ferrier Research Institute, Victoria University of Wellington , P.O. Box 600, Wellington 6140, New Zealand
| | - Taryn L Osmond
- Malaghan Institute of Medical Research , P.O. Box 7060, Wellington 6242, New Zealand
| | - Colin M Hayman
- The Ferrier Research Institute, Victoria University of Wellington , P.O. Box 600, Wellington 6140, New Zealand
| | - David S Larsen
- Department of Chemistry, University of Otago , P.O. Box 56, Dunedin 9054, New Zealand
| | - Ian F Hermans
- Malaghan Institute of Medical Research , P.O. Box 7060, Wellington 6242, New Zealand.,School of Biological Sciences, Victoria University of Wellington , P.O. Box 600, Wellington 6140, New Zealand.,Maurice Wilkins Centre for Molecular Biodiscovery , 3 Symonds Street, Auckland Central 1142, New Zealand
| | - Gavin F Painter
- The Ferrier Research Institute, Victoria University of Wellington , P.O. Box 600, Wellington 6140, New Zealand.,Maurice Wilkins Centre for Molecular Biodiscovery , 3 Symonds Street, Auckland Central 1142, New Zealand
| |
Collapse
|
3
|
|
4
|
Laurent X, Bertin B, Renault N, Farce A, Speca S, Milhomme O, Millet R, Desreumaux P, Hénon E, Chavatte P. Switching Invariant Natural Killer T (iNKT) Cell Response from Anticancerous to Anti-Inflammatory Effect: Molecular Bases. J Med Chem 2014; 57:5489-508. [DOI: 10.1021/jm4010863] [Citation(s) in RCA: 55] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Affiliation(s)
- Xavier Laurent
- Faculté
de Médecine, Intestinal Biotech Development, Amphis J et K, Boulevard du Professeur Jules Leclerc, 59045 Lille Cedex, France
- Laboratoire
de Chimie Thérapeutique, EA 4481, Faculté des Sciences
Pharmaceutiques et Biologiques, Université Lille-Nord de France, 3 Rue du Professeur Laguesse, BP 83, 59006 Lille Cedex, France
| | - Benjamin Bertin
- Faculté
de
Médecine, Université Lille-Nord de France, Amphis J
et K, INSERM U995, Boulevard du Professeur
Jules Leclerc, 59045 Lille Cedex, France
| | - Nicolas Renault
- Laboratoire
de Chimie Thérapeutique, EA 4481, Faculté des Sciences
Pharmaceutiques et Biologiques, Université Lille-Nord de France, 3 Rue du Professeur Laguesse, BP 83, 59006 Lille Cedex, France
| | - Amaury Farce
- Laboratoire
de Chimie Thérapeutique, EA 4481, Faculté des Sciences
Pharmaceutiques et Biologiques, Université Lille-Nord de France, 3 Rue du Professeur Laguesse, BP 83, 59006 Lille Cedex, France
| | - Silvia Speca
- Faculté
de
Médecine, Université Lille-Nord de France, Amphis J
et K, INSERM U995, Boulevard du Professeur
Jules Leclerc, 59045 Lille Cedex, France
| | - Ophélie Milhomme
- Institut
de Chimie Pharmaceutique Albert Lespagnol, EA 4481, Université Lille-Nord de France, 3 Rue du Professeur Laguesse, BP 83, 59006 Lille Cedex, France
| | - Régis Millet
- Institut
de Chimie Pharmaceutique Albert Lespagnol, EA 4481, Université Lille-Nord de France, 3 Rue du Professeur Laguesse, BP 83, 59006 Lille Cedex, France
| | - Pierre Desreumaux
- Faculté
de
Médecine, Université Lille-Nord de France, Amphis J
et K, INSERM U995, Boulevard du Professeur
Jules Leclerc, 59045 Lille Cedex, France
| | - Eric Hénon
- Université
de Reims Champagne-Ardenne, UFR des Sciences Exactes et Naturelles,
BSMA-ICMR, UMR CNRS 6229, Moulin de
la Housse, BP 1039, 51687 Reims Cedex 2, France
| | - Philippe Chavatte
- Laboratoire
de Chimie Thérapeutique, EA 4481, Faculté des Sciences
Pharmaceutiques et Biologiques, Université Lille-Nord de France, 3 Rue du Professeur Laguesse, BP 83, 59006 Lille Cedex, France
- Institut
de Chimie Pharmaceutique Albert Lespagnol, EA 4481, Université Lille-Nord de France, 3 Rue du Professeur Laguesse, BP 83, 59006 Lille Cedex, France
| |
Collapse
|
5
|
Anderson BL, Teyton L, Bendelac A, Savage PB. Stimulation of natural killer T cells by glycolipids. Molecules 2013; 18:15662-88. [PMID: 24352021 PMCID: PMC4018217 DOI: 10.3390/molecules181215662] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2013] [Revised: 12/11/2013] [Accepted: 12/11/2013] [Indexed: 01/31/2023] Open
Abstract
Natural killer T (NKT) cells are a subset of T cells that recognize glycolipid antigens presented by the CD1d protein. The initial discovery of immunostimulatory glycolipids from a marine sponge and the T cells that respond to the compounds has led to extensive research by chemists and immunologists to understand how glycolipids are recognized, possible responses by NKT cells, and the structural features of glycolipids necessary for stimulatory activity. The presence of this cell type in humans and most mammals suggests that it plays critical roles in antigen recognition and the interface between innate and adaptive immunity. Both endogenous and exogenous natural antigens for NKT cells have been identified, and it is likely that glycolipid antigens remain to be discovered. Multiple series of structurally varied glycolipids have been synthesized and tested for stimulatory activity. The structural features of glycolipids necessary for NKT cell stimulation are moderately well understood, and designed compounds have proven to be much more potent antigens than their natural counterparts. Nevertheless, control over NKT cell responses by designed glycolipids has not been optimized, and further research will be required to fully reveal the therapeutic potential of this cell type.
Collapse
Affiliation(s)
| | | | | | - Paul B Savage
- Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.
| |
Collapse
|
6
|
Stocker BL, Timmer MSM. Chemical Tools for Studying the Biological Function of Glycolipids. Chembiochem 2013; 14:1164-84. [DOI: 10.1002/cbic.201300064] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2013] [Indexed: 01/04/2023]
|
7
|
East JE, Kennedy AJ, Webb TJ. Raising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells. Med Res Rev 2012; 34:45-76. [PMID: 23239102 DOI: 10.1002/med.21276] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Natural killer T (NKT) cells serve as a bridge between the innate and adaptive immune systems, and manipulating their effector functions can have therapeutic significances in the treatment of autoimmunity, transplant biology, infectious disease, and cancer. NKT cells are a subset of T cells that express cell-surface markers characteristic of both natural killer cells and T cells. These unique immunologic cells have been demonstrated to serve as a link between the innate and adaptive immune systems through their potent cytokine production following the recognition of a range of lipid antigens, mediated through presentation of the major histocompatibility complex (MHC) class I like CD1d molecule, in addition to the NKT cell's cytotoxic capabilities upon activation. Although a number of glycolipid antigens have been shown to complex with CD1d molecules, most notably the marine sponge derived glycolipid alpha-galactosylceramide (α-GalCer), there has been debate as to the identity of the endogenous activating lipid presented to the T-cell receptor (TCR) via the CD1d molecule on antigen-presenting cells (APCs). This review aims to survey the use of pharmacological agents and subsequent structure-activity relationships (SAR) that have given insight into the binding interaction of glycolipids with both the CD1d molecules as well as the TCR and the subsequent immunologic response of NKT cells. These studies not only elucidate basic binding interactions but also pave the way for future pharmacological modulation of NKT cell responses.
Collapse
Affiliation(s)
- James E East
- Department of Microbiology and Immunology, The Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland 21201
| | | | | |
Collapse
|
8
|
Gallo RM, Khan MA, Shi J, Kapur R, Wei L, Bailey JC, Liu J, Brutkiewicz RR. Regulation of the actin cytoskeleton by Rho kinase controls antigen presentation by CD1d. THE JOURNAL OF IMMUNOLOGY 2012; 189:1689-98. [PMID: 22798677 DOI: 10.4049/jimmunol.1101484] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
CD1d molecules are MHC class I-like molecules that present lipid Ags to NKT cells. Although we have previously shown that several different cell signaling molecules can play a role in the control of Ag presentation by CD1d, a defined mechanism by which a cell signaling pathway regulates CD1d function has been unclear. In the current study, we have found that the Rho kinases, Rho-associated, coiled-coil containing protein kinase (ROCK)1 and ROCK2, negatively regulate both human and mouse CD1d-mediated Ag presentation. Inhibition of ROCK pharmacologically, through specific ROCK1 and ROCK2 short hairpin RNA, or by using dendritic cells generated from ROCK1-deficient mice all resulted in enhanced CD1d-mediated Ag presentation compared with controls. ROCK regulates the actin cytoskeleton by phosphorylating LIM kinase, which, in turn, phosphorylates cofilin, prohibiting actin fiber depolymerization. Treatment of APCs with the actin filament depolymerizing agent, cytochalasin D, as well as knockdown of LIM kinase by short hairpin RNA, resulted in enhanced Ag presentation to NKT cells by CD1d, consistent with our ROCK inhibition data. Therefore, our overall results reveal a model whereby CD1d-mediated Ag presentation is negatively regulated by ROCK via its effects on the actin cytoskeleton.
Collapse
Affiliation(s)
- Richard M Gallo
- Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA
| | | | | | | | | | | | | | | |
Collapse
|
9
|
Use of the NEO strategy (Nucleophilic addition/Epoxide Opening) for the synthesis of a new C-galactoside ester analogue of KRN 7000. Bioorg Med Chem Lett 2011; 21:2510-4. [DOI: 10.1016/j.bmcl.2011.02.044] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2011] [Revised: 02/10/2011] [Accepted: 02/12/2011] [Indexed: 11/23/2022]
|
10
|
Banchet-Cadeddu A, Hénon E, Dauchez M, Renault JH, Monneaux F, Haudrechy A. The stimulating adventure of KRN 7000. Org Biomol Chem 2011; 9:3080-104. [DOI: 10.1039/c0ob00975j] [Citation(s) in RCA: 115] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
11
|
Tashiro T, Mori K. Fifteen Years since the Development of KRN7000 – Structure-Activity Relationship Studies on Novel Glycosphingolipids Which Stimulate Natural Killer T Cells. TRENDS GLYCOSCI GLYC 2010. [DOI: 10.4052/tigg.22.280] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
12
|
Michieletti M, Bracci A, Compostella F, De Libero G, Mori L, Fallarini S, Lombardi G, Panza L. Synthesis of alpha-galactosyl ceramide (KRN7000) and analogues thereof via a common precursor and their preliminary biological assessment. J Org Chem 2008; 73:9192-5. [PMID: 18956839 DOI: 10.1021/jo8019994] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
A new practical synthesis of alpha-GalCer and of its analogues is presented, opening the chance to easily modify the sphingosine chain. The common precursor is a disaccharide, obtained by coupling tetra-O-benzyl-D-galactose with allyl 2,3-O-isopropylidene-D-lyxofuranoside. Introduction of alkyl chains via Wittig reaction (for alpha-GalCer and OCH) or via Williamson reaction (for oxa analogues) followed by standard synthetic steps allows one to efficiently obtain such compounds. The analogues are able to activate iNKT cells when presented by CD1d expressing cells.
Collapse
Affiliation(s)
- Mario Michieletti
- Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche, Università del Piemonte Orientale Amedeo Avogadro, via Bovio 6, 28100 Novara, Italy
| | | | | | | | | | | | | | | |
Collapse
|